Dr. Michael Toboni, MD

Dr. Toboni practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Toboni's NPI, 1750769568, was assigned on May 12, 2015. Dr. Toboni graduated from University of Southern California Keck School of Medicine in 2015. Dr. Toboni holds Alabama license 35450.

Dr. Toboni's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Dr. Toboni's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Toboni is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toboni practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Toboni's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Toboni's licenses on file in 2 states: Alabama and Missouri.

CMS data shows 141 Medicare services from Dr. Toboni across 5 procedure codes in 2024, for 60 Medicare patients. Medicare paid $7,563 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Toboni in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 60% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toboni's median patient age at 61, with 100% women.

In 2024, Dr. Toboni wrote 122 Medicare Part D claims for 60 patients. 86% of them were for generic drugs. CMS names the drug for 68 of them, across 3 drugs with 11 or more claims each, at $6,622 in total drug cost. In 2023, CMS named 48 claims across 2 drugs.

Dr. Toboni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of removal of the uterus by Dr. Toboni, more than 90% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Toboni, published from 2011 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Uterine Neoplasms, Carcinosarcoma and Biomarkers, Tumor. Dr. Toboni has published most often in Gynecol Oncol. Dr. Toboni's most frequent co-authors are Premal Harish Thaker, MD, Rebecca Arend, MD and Thomas John Herzog, MD.

Dmand AI links Dr. Toboni to 1 clinical trial. Conditions studied include Ileus and Intestinal Obstruction.

CMS Open Payments shows 23 general payments to Dr. Toboni from 7 drug and device companies from 2019 to 2025. Education make up the largest share, 64% of the total. Intuitive Surgical, Inc. paid the most, $6,664.

Dr. Toboni graduated from University of Southern California Keck School of Medicine in 2015.